AI Gastroenterology Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 524.0 million
Estimated Base Value
2035 Forecast
US$ 3.3 billion
Projected Market Value
CAGR 2026–2035
20.2%
Compound Annual Growth
Largest Segment
AI-powered Diagnostic Platforms
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
Asia Pacific
Fastest Growing Region
Middle East & Africa
Top Country
United States
By Market Share
Largest market
Key Players
Iterative Health
Emerging Players
Freenome, Gutfeeling.ai
AI Gastroenterology Market Overview
The AI Gastroenterology Market involves the application of artificial intelligence technologies, such as machine learning, deep learning, natural language processing, and computer vision, to improve gastrointestinal healthcare. This includes AI-powered solutions for diagnosing GI disorders, optimizing treatment plans, predicting disease progression, and personalizing patient care. Key applications range from AI-assisted endoscopic image analysis for polyp detection to predictive analytics for inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). The market serves a diverse range of buyers including hospitals, specialty clinics, academic institutions, diagnostic centers, pharmaceutical companies, and telehealth providers seeking to enhance diagnostic accuracy, treatment efficiency, and patient outcomes.
The AI Gastroenterology Market is estimated at $524.0 Mn in 2025 and is forecast to reach $3.3 Bn in 2035, growing at a CAGR of 20.2% from 2025 to 2035. Demand is driven by the need for accurate and early GI disease detection, the increasing incidence of chronic gastrointestinal disorders, and ongoing technological advancements in AI. However, market growth is constrained by the limited availability of high-quality gastroenterology datasets for AI training, the high costs associated with development and integration, and regulatory complexities that can slow market entry for new AI solutions.
The market is segmented by Type (AI-Powered Diagnostic Platforms, AI-Assisted Therapeutic Guidance Systems), Technology (Machine Learning, Deep Learning), Application (Colonoscopy & Endoscopy Assistance, Inflammatory Bowel Disease Management), End-User (Hospitals, Specialty Clinics & Gastroenterology Practices), Deployment (Cloud-Based, On-Premise), and Component (Software, Hardware). Geographically, the market is served across Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Leading companies include Iterative Health, Cosmo Pharmaceuticals, Wision A.I., and Vivante Health. The full report provides an in-depth analysis of these segments, market dynamics, and competitive landscape.
Market Definition & Overview
The AI Gastroenterology Market encompasses the development, deployment, and adoption of artificial intelligence technologies—including machine learning, deep learning, natural language processing, and computer vision—to enhance various aspects of gastrointestinal healthcare. This market covers AI-powered solutions aimed at improving the accuracy and efficiency of diagnosing GI disorders, optimizing treatment planning, predicting disease progression, and personalizing patient care. Key applications include AI-assisted endoscopic image analysis for polyp detection and characterization, predictive analytics for inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), automated pathology analysis of GI biopsies, and intelligent systems for drug discovery in gastroenterology, ultimately driving better patient outcomes and operational efficiencies within the healthcare system.
Scope
- Global market coverage across all major regions.
- Focus on commercially available AI software, platforms, and services for gastroenterology.
- Market analysis spans the period from 2025 to 2035.
Inclusions
- AI-assisted diagnostic tools for endoscopy (colonoscopy, gastroscopy) to detect polyps and lesions.
- Predictive analytics and risk stratification models for inflammatory bowel disease (IBD) and other chronic GI conditions.
- AI algorithms for personalized treatment planning and drug efficacy prediction in gastroenterology.
- Machine learning applications for pathology image analysis in gastrointestinal cancers.
- Natural Language Processing (NLP) tools for analyzing clinical notes and patient data in GI.
- AI-powered platforms for remote monitoring and management of GI patients.
Exclusions
- General-purpose AI platforms not specifically adapted for gastroenterology applications.
- Traditional, non-AI medical devices and imaging equipment used in gastroenterology.
- AI applications in other medical specialties such as cardiology, oncology (outside GI), or neurology.
- Basic data analytics tools lacking advanced AI or machine learning capabilities.
- Pure academic research on AI in gastroenterology without commercialization intent.
Market Size Forecast
Executive Summary
• The AI Gastroenterology market is valued at $524.0 Mn in 2025 and is forecast to reach $3.3 Bn by 2035, reflecting a robust CAGR of 20.2% as demand accelerates across every major segment and region over the ten-year outlook.
• AI-powered Diagnostic Platforms leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at XX.X%, while Emerging Areas is expanding the fastest at a XX.X% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• The AI gastroenterology market is rapidly consolidating, driven by strategic acquisitions from established medical device firms and tech giants aiming to integrate advanced diagnostic and therapeutic AI solutions, fundamentally reshaping the competitive landscape and innovation trajectory.
• Key growth catalysts include the demonstrable clinical efficacy of AI in enhancing diagnostic precision for conditions like colorectal cancer and IBD, alongside its role in streamlining procedural workflows, significantly improving patient outcomes and clinician efficiency globally.
• Increasing regulatory clarity for AI-powered diagnostics and therapeutic support tools is de-risking investments, attracting substantial venture capital into specialized AI firms and fostering critical partnerships necessary for broad market adoption and scale.
• While developed markets currently lead adoption due to advanced infrastructure and reimbursement frameworks, emerging economies present substantial long-term growth potential, particularly for cost-effective AI solutions addressing widespread gastrointestinal diseases.
• The evolution towards real-time AI integration within endoscopy platforms and personalized predictive analytics represents a pivotal technological shift, promising to transform preventive care strategies and precision medicine applications across all GI segments.
• Ensuring robust, diverse real-world data access and developing secure, interoperable AI platforms are paramount strategic imperatives, dictating future supply chain resilience and successful AI solution deployment across diverse clinical settings worldwide.
Key Market Takeaways
Critical findings and data points from this market research study.
Initial Market Valuation
The AI Gastroenterology Market was valued at an impressive $524.0 million in the base year, indicating a robust foundation for future growth.
Substantial Future Growth
The market is projected to achieve significant expansion, reaching $3.3 billion by the forecast year, demonstrating strong market potential.
High Growth Rate
This substantial market increase is driven by an impressive Compound Annual Growth Rate (CAGR) of 20.2% over the forecast period.
Diagnostic AI Leads
Diagnostic AI solutions are expected to emerge as a leading segment, spearheading market growth through enhanced accuracy and efficiency in disease detection.
Predictive Analytics Trend
A notable trend in the market is the increasing integration of predictive analytics, offering advanced insights for proactive disease management and personalized patient care.
Significant Market Expansion
The AI Gastroenterology Market is poised for nearly eightfold expansion from its base year value of $524.0 million to $3.3 billion, signaling a dynamic and rapidly evolving sector.
Market Dynamics
Market Trends
- Growing AI integration in endoscopic imaging and analysis.
- Shift towards AI for predictive diagnosis of GI conditions.
- Increased adoption of AI in GI research and drug development.
- Focus on AI for personalized treatment plans in gastroenterology.
Growth Drivers
- High demand for accurate and early GI disease detection.
- Rising incidence of chronic gastrointestinal disorders globally.
- Technological advancements in AI and machine learning algorithms.
- Need to improve efficiency and reduce diagnostic errors.
Restraints
- Limited availability of large, high-quality gastroenterology datasets hinders AI training.
- High development and integration costs challenge widespread AI adoption in clinics.
- Regulatory complexities and slow approval processes impede market entry for AI solutions.
- Physician skepticism and trust issues concerning AI accuracy slow clinical acceptance.
Opportunities
- Developing AI solutions for remote monitoring of GI patients.
- Expanding AI applications in preventative gastroenterology.
- Creating AI platforms for precision medicine in GI treatments.
- Market penetration into underserved regions with high GI disease burden.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | AI-Powered Diagnostic PlatformsAI-Assisted Therapeutic Guidance SystemsAI for Disease Surveillance & Patient MonitoringAI in GI Drug Discovery & DevelopmentAI-Driven Clinical Workflow & Operational OptimizationAI for Predictive Analytics & Risk Stratification |
| By Technology | Machine LearningDeep LearningNatural Language ProcessingComputer VisionPredictive AnalyticsRobotics and AutomationRule-Based AI Systems |
| By Application | Colonoscopy & Endoscopy AssistanceInflammatory Bowel Disease ManagementGastroesophageal Reflux Disease & Esophageal DisordersHepatology & Liver DiseasesPancreatic & Biliary DisordersGastric & Small Bowel DisordersFunctional GI DisordersGastrointestinal Oncology |
| By End-User | HospitalsSpecialty Clinics & Gastroenterology PracticesAcademic & Research InstitutionsDiagnostic & Imaging CentersAmbulatory Surgical CentersPharmaceutical & Biotechnology CompaniesTelehealth & Remote Care Providers |
| By Deployment | Cloud-BasedOn-PremiseHybrid |
| By Component | SoftwareHardwareServices |
Regional Analysis
- North America leads the AI Gastroenterology market due to substantial healthcare IT investments, high adoption of advanced technologies, and a robust R&D ecosystem. The region's major AI solution providers and supportive regulatory frameworks further solidify its dominant position.
- Asia-Pacific is projected to be the fastest-growing region, fueled by its immense patient population, increasing healthcare IT infrastructure development, and rising awareness of AI's diagnostic benefits. Government support for digital health initiatives also significantly contributes to this rapid expansion.
- In Europe, there's a noteworthy trend towards integrating AI-powered GI solutions within established digital health ecosystems, emphasizing data privacy and interoperability. This focus ensures secure and efficient sharing of patient data across diverse healthcare providers for collaborative patient management.
| Asia PacificXX.X% | North AmericaXX.X% | EuropeXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Characterized by advanced healthcare infrastructure, high R&D investment, and strong adoption of cutting-edge AI solutions for diagnostics and treatment in gastroenterology.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- An emerging market with significant growth potential, fueled by increasing investment in healthcare infrastructure and a growing demand for advanced diagnostic and therapeutic tools, despite economic hurdles.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Benefits from robust healthcare systems and a focus on digital health, though market penetration can vary due to diverse regulatory landscapes and differing adoption rates across countries.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Driven by large patient populations, increasing healthcare expenditure, and rapid adoption of AI technologies in major economies like China, India, and Japan, making it the leading market.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Shows promising growth, particularly in Gulf Cooperation Council (GCC) countries with high healthcare spending, while other parts of the region present both opportunities and challenges for AI adoption.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The U.S. leads in AI gastroenterology due to its vast healthcare expenditure, high adoption of advanced medical technologies, and significant prevalence of chronic GI diseases. Strong R&D and private investment further drive innovation and market growth. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | As the largest economy in Latin America, Brazil's AI gastroenterology market is propelled by a large population, increasing digital health adoption, and efforts to improve access to advanced diagnostic and treatment technologies. |
| 3 | Germany | US$ XX.X Mn | XX.X% | Germany's advanced healthcare system and strong medical technology sector drive the adoption of AI in gastroenterology, focusing on high-precision diagnostics and personalized treatment approaches, backed by robust data protection standards. |
| 4 | China | US$ XX.X Mn | XX.X% | China's massive healthcare market, rapid technological advancement, and strong government backing for AI integration in medicine make it a dominant player in AI gastroenterology, especially in diagnostics and clinical decision support. |
| 5 | Saudi Arabia | US$ XX.X Mn | XX.X% | Driven by Vision 2030 and significant healthcare investments, Saudi Arabia is rapidly adopting AI in gastroenterology to modernize its healthcare system, improve diagnostic capabilities, and deliver advanced patient care. |
Countries Covered (25)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, United Kingdom, France, Spain, Italy, Russia, Rest of Europe, China, India, Japan, South Korea, Australia, Taiwan, Malaysia, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Iterative Health | XX.X% | Leverage AI to improve colonoscopy quality and clinical trial recruitment efficiency in gastroenterology. | — | — | SKOUTAI-powered polyp detectionPrecision Enrollment |
| 2 | Cosmo Pharmaceuticals | XX.X% | Develop and commercialize innovative medical devices and pharmaceuticals for gastrointestinal health through R&D and acquisitions. | — | — | EleviewLuminal imaging capsuleMethylene Blue MMX+1 |
| 3 | Wision A.I. | XX.X% | Focus on developing AI-assisted diagnostic tools to enhance the detection and characterization of lesions in endoscopic procedures. | — | — | EndoScreenerEndoScreener GIEndoScreener Colon |
| 4 | Vivante Health | XX.X% | Provide a comprehensive digital health solution for digestive diseases, integrating diet, lifestyle, and clinical support. | — | — | GIThrivePersonalized nutrition plansMental health support for GI conditions |
| 5 | Day Two | XX.X% | Utilize gut microbiome profiling and AI to provide personalized nutrition recommendations for metabolic and GI health. | — | — | Personalized nutrition programGut microbiome analysisPrediabetes management |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Iterative Health, Cosmo Pharmaceuticals, Wision A.I., Vivante Health, Day Two, Viome Life Sciences, Mahana Therapeutics, Magentiq Eye, Salvo Health, MetaMe Health, Oshi Health, Medial EarlySign, Endolumina, KML Vision, Augmented Endoscopy, Pangea Biomed, Preserving Life Systems, Niron Kolon, EndoScan Technologies, Dieta Health
The global AI Gastroenterology market features a competitive landscape led by Iterative Health, Cosmo Pharmaceuticals, Wision A.I., Vivante Health, Day Two, and Viome Life Sciences, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
Iterative Health
Cosmo Pharmaceuticals
Wision A.I.
Vivante Health
Day Two
Viome Life Sciences
Mahana Therapeutics
Magentiq Eye
Salvo Health
MetaMe Health
Oshi Health
Medial EarlySign
Endolumina
KML Vision
Augmented Endoscopy
Pangea Biomed
Preserving Life Systems
Niron Kolon
EndoScan Technologies
Dieta Health
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
MedTech Giant Unveils Next-Gen AI for Colonoscopy
A leading medical technology company has launched its innovative AI-powered system designed to enhance polyp detection during colonoscopies, demonstrating significantly improved adenoma detection rates in clinical trials. This new platform aims to reduce missed lesions and improve early cancer detection.
Pharma Leader Partners with AI Firm for Personalized IBD Therapy
A major pharmaceutical company announced a strategic partnership with a specialized AI firm to leverage machine learning for predicting patient response to IBD treatments and developing personalized therapeutic strategies. The collaboration seeks to optimize drug efficacy and improve patient outcomes in inflammatory bowel disease.
Healthcare Tech Giant Acquires AI-Driven Digestive Health Platform
A prominent healthcare technology conglomerate has acquired a fast-growing startup known for its AI-powered digital platform offering personalized dietary recommendations and symptom tracking for various GI conditions. This acquisition expands the conglomerate's footprint in precision digestive health and patient-centric care.
AI GI Predictive Analytics Startup Secures US$ XX.X in Series B Funding
A startup focused on AI-driven predictive analytics for early detection and risk stratification of gastrointestinal diseases has successfully closed a US$ XX.X Series B funding round. The investment will fuel product development, clinical validation, and global expansion of its platform, which helps clinicians proactively manage patient health.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $524.0 Mn |
| Market Size (Forecast) | $3.3 Bn |
| CAGR | 20.2% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 25 Countries |
| Segments Covered | 6 Segments, 34 Sub-segments |
| Companies Profiled | 32 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the AI Gastroenterology Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
VP, Corporate Strategy
Industrial manufacturing company
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Director, Investment Research
Private equity firm
“We now use these reports in every planning cycle. The regional granularity, and the same numbers across the report, the dashboard and the Excel, save our team real time.”
Head of Market Intelligence
Specialty chemicals company
Frequently Asked Questions
Common questions about this report and our research
The AI Gastroenterology market is estimated at $524.0 Mn in 2025. It is forecast to reach $3.3 Bn in 2035, indicating substantial growth over the forecast period.
The AI Gastroenterology market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 20.2% from 2025 to 2035. This growth is driven by increasing demand for early disease detection and technological advancements.
The main segments include Type (AI-Powered Diagnostic Platforms), Technology (Machine Learning), Application (Colonoscopy & Endoscopy Assistance), End-User (Hospitals), Deployment (Cloud-Based), and Component (Software).
Leading companies in the AI Gastroenterology market include Iterative Health, Cosmo Pharmaceuticals, Wision A.I., Vivante Health, Day Two, Viome Life Sciences, Mahana Therapeutics, Magentiq Eye, Salvo Health, MetaMe Health, Oshi Health, and Medial EarlySign.
The report covers market size and growth, segmentation by Type, Technology, Application, End-User, Deployment, and Component, and regional analysis across Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. It also profiles key companies.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
AI Pathology Market
$600.0 Mn in 2025 · 20.9% CAGR
AI Radiology Workflow Market
$756.0 Mn in 2025 · 16.2% CAGR
Cancer Screening AI Market
$1.7 Bn in 2025 · 18.8% CAGR
Clinical Genomic Interpretation Market
$3.2 Bn in 2025 · 13.8% CAGR
Precision Wellness Market
$12.8 Bn in 2025 · 11.7% CAGR
AI Agents for Healthcare Market
$1.2 Bn in 2025 · 25.0% CAGR
AI Care Coordination Platform Market
$1.1 Bn in 2025 · 21.2% CAGR
AI Caregiver Support Systems Market
$100.0 Mn in 2025 · 25.9% CAGR